Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 34295, 5 pages
http://dx.doi.org/10.1155/MI/2006/34295
Research Communication

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis

1Department of Gastroenterology, School of Medicine, Firat University, Elazig 23200, Turkey
2Department of Biochemistry, School of Medicine, Firat University, Elazig 23200, Turkey
3Department of Immunology, School of Medicine, Firat University, Elazig 23200, Turkey
4Department of Microbiology, School of Medicine, Firat University, Elazig 23200, Turkey

Received 22 May 2006; Revised 23 August 2006; Accepted 23 August 2006

Copyright © 2006 Mehmet Yalniz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [32 citations]

The following is the list of published articles that have cited the current article.

  • Zobair M. Younossi, Mohammed Jarrar, Clare Nugent, Manpreet Randhawa, Mariam Afendy, Maria Stepanova, Nila Rafiq, Zachary Goodman, Vikas Chandhoke, and Ancha Baranova, “A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH),” Obesity Surgery, vol. 18, no. 11, pp. 1430–1437, 2008. View at Publisher · View at Google Scholar
  • Yoshihiro Kamada, Tetsuo Takehara, and Norio Hayashi, “Adipocytokines and liver disease,” Journal of Gastroenterology, vol. 43, no. 11, pp. 811–822, 2008. View at Publisher · View at Google Scholar
  • Marianna Argentou, Dina G. Tiniakos, Menelaos Karanikolas, Maria Melachrinou, Maria G. Makri, Christos Kittas, and Fotis Kalfarentzos, “Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery,” Obesity Surgery, vol. 19, no. 9, pp. 1313–1323, 2009. View at Publisher · View at Google Scholar
  • Yusuf Yilmaz, Alla Eldeen Kedrah, and Osman Ozdogan, “Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis,” World Journal Of Gastroenterology, vol. 15, no. 35, pp. 4387–4391, 2009. View at Publisher · View at Google Scholar
  • Juichi Fukushima, Yoshihiro Kamada, Hitoshi Matsumoto, Yuichi Yoshida, Hisao Ezaki, Takayo Takemura, Yukiko Saji, Takumi Igura, Shusaku Tsutsui, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, and Norio Hayashi, “Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization,” Hepatology Research, vol. 39, no. 7, pp. 724–738, 2009. View at Publisher · View at Google Scholar
  • P. Tessari, A. Coracina, A. Cosma, and A. Tiengo, “Hepatic lipid metabolism and non-alcoholic fatty liver disease,” Nutrition Metabolism and Cardiovascular Diseases, vol. 19, no. 4, pp. 291–302, 2009. View at Publisher · View at Google Scholar
  • Lascelles E. Lyn-Cook, Margot Lawton, Ming Tong, Elizabeth Silbermann, Lisa Longato, Ping Jiao, Princess Mark, Jack R. Wands, Haiyan Xu, and Suzanne M. de la Monte, “Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis,” Journal Of Alzheimers Disease, vol. 16, no. 4, pp. 715–729, 2009. View at Publisher · View at Google Scholar
  • Ming Tong, and Suzanne M. de la Monte, “Mechanisms of Ceramide-Mediated Neurodegeneration,” Journal of Alzheimers Disease, vol. 16, no. 4, pp. 705–714, 2009. View at Publisher · View at Google Scholar
  • D. M. Lebensztejn, D. Kowalczuk, E. Tarasow, E. Skiba, and M. Kaczmarski, “Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD,” Advances In Medical Sciences, vol. 55, no. 1, pp. 74–79, 2010. View at Publisher · View at Google Scholar
  • Ahmed Abu-Shanab, and Eamonn M. M. Quigley, “The role of the gut microbiota in nonalcoholic fatty liver disease,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 12, pp. 691–701, 2010. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, Ming Tong, VanAnh Nguyen, Mashiko Setshedi, Lisa Longato, and Jack R. Wands, “Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions,” Journal Of Alzheimers Disease, vol. 21, no. 3, pp. 967–984, 2010. View at Publisher · View at Google Scholar
  • Stergios A. Polyzos, Konstantinos A. Toulis, Dimitrios G. Goulis, Christos Zavos, and Jannis Kountouras, “Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis,” Metabolism, vol. 60, no. 3, pp. 313–326, 2011. View at Publisher · View at Google Scholar
  • Ahmed Elbadri, Serag Esmat, Nihal Abosaif, Ahmed Morsi, and Olfat Shaker, “Study of serum ghrelin changes and its correlation with malnutrition in liver cirrhosis in Egypt,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 10, pp. 638–643, 2011. View at Publisher · View at Google Scholar
  • Suzanne M. De La Monte, Jack R. Wands, Lascelles E. Lyn-Cook Jr., Margot Lawton, Ming Tong, Elizabeth Silbermann, Lisa Longato, Ping Jiao, Princess Mark, and Haiyan Xu, “Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis,” Advances in Alzheimer's Disease, vol. 1, pp. 179–199, 2011. View at Publisher · View at Google Scholar
  • Maciej Gonciarz, Wladyslaw Bielański, Robert Partyka, Tomasz Brzozowski, Piotr C. Konturek, Jerzy Eszyk, Krzysztof Celiński, Russel J. Reiter, and Stanislaw J. Konturek, “Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin,” Journal of Pineal Research, vol. 54, no. 2, pp. 154–161, 2012. View at Publisher · View at Google Scholar
  • Zulfikar Polat, Guldem Kilciler, A. Melih Ozel, Muammer Kara, Murat Kantarcioglu, Ahmet Uygun, and Sait Bagci, “Plasma Ghrelin Levels in Patients with Familial Mediterranean Fever,” Digestive Diseases and Sciences, vol. 57, no. 6, pp. 1660–1663, 2012. View at Publisher · View at Google Scholar
  • Daniel Crona, and Robert MacLaren, “Gastrointestinal hormone concentrations associated with gastric feeding in critically ill patients,” Journal of Parenteral and Enteral Nutrition, vol. 36, no. 2, pp. 189–196, 2012. View at Publisher · View at Google Scholar
  • Marten Heeringa, Ann Hastings, Shunji Yamazaki, and Paul de Koning, “Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?,” Biomarkers in Medicine, vol. 6, no. 6, pp. 743–757, 2012. View at Publisher · View at Google Scholar
  • Rocio Aller, Daniel De Luis, David Pacheco, Maria Concepcion Velasco, Olatz Izaola, and Manuel Gonzalez Sagrado, “Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery,” Journal of Investigative Medicine, vol. 60, no. 7, pp. 1005–1008, 2012. View at Publisher · View at Google Scholar
  • Mariana V. Machado, João Coutinho, Fátima Carepa, Adília Costa, Helena Proença, and Helena Cortez-Pinto, “How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease,” European Journal of Gastroenterology & Hepatology, vol. 24, no. 10, pp. 1166–1172, 2012. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, “Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed,” Journal Of Alzheimers Disease, vol. 30, pp. S231–S249, 2012. View at Publisher · View at Google Scholar
  • David Pacheco, Maria Concepcion Velasco, Olatz Izaola, Rocio Aller, Daniel De Luis, and Manuel Gonzalez Sagrado, “Insulin Resistance Predicts Steatosis and Fibrosis in Morbidly Obese Patients Undergoing Bariatric Surgery,” Journal of Investigative Medicine, vol. 60, no. 7, pp. 1005–1008, 2012. View at Publisher · View at Google Scholar
  • Yosho Fukita, Tsutoshi Asaki, Yoshiki Katakura, and Ichiro Shimizupp. 94–106, 2012. View at Publisher · View at Google Scholar
  • Gabor Firneisz, “Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?,” World Journal of Gastroenterology, vol. 20, no. 27, pp. 9072–9089, 2014. View at Publisher · View at Google Scholar
  • T.E. Silva, G. Colombo, and L.L. Schiavon, “Adiponectin: A multitasking player in the field of liver diseases,” Diabetes & Metabolism, vol. 40, no. 2, pp. 95–107, 2014. View at Publisher · View at Google Scholar
  • Haiyin Zheng, Jinyan Zhao, Yuqiing Zheng, Juan Wu, Yan Liu, Jun Peng, and Zhenfeng Hong, “Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non-alcoholic fatty liver disease in rats,” Molecular Medicine Reports, vol. 10, no. 4, pp. 1758–1764, 2014. View at Publisher · View at Google Scholar
  • Stergios A. Polyzos, Konstantinos N. Aronis, Jannis Kountouras, Dimitrios D. Raptis, Maria F. Vasiloglou, and Christos S. Mantzoros, “Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis,” Diabetologia, 2015. View at Publisher · View at Google Scholar
  • Gianluca Gortan Cappellari, Michela Zanetti, Annamaria Semolic, Pierandrea Vinci, Giulia Ruozi, Margherita De Nardo, Nicoletta Filigheddu, Gianfranco Guarnieri, Mauro Giacca, Andrea Graziani, and Rocco Barazzoni, “Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo,” Clinical Nutrition Experimental, 2015. View at Publisher · View at Google Scholar
  • Stergios A. Polyzos, Jannis Kountouras, and Christos S. Mantzoros, “Leptin in nonalcoholic fatty liver disease: A narrative review,” Metabolism-Clinical And Experimental, vol. 64, no. 1, pp. 60–78, 2015. View at Publisher · View at Google Scholar
  • Jacquelyn J. Maherpp. 71–101, 2015. View at Publisher · View at Google Scholar
  • Harry Robberecht, and Nina Hermans, “Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance,” Metabolic Syndrome and Related Disorders, 2016. View at Publisher · View at Google Scholar
  • Seyyed Mortaza Haghgoo, Heidar Sharafi, and Seyed Moayed Alavian, “Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review,” Clinical Chemistry and Laboratory Medicine (CCLM), no. 0, 2018. View at Publisher · View at Google Scholar